MyFinsight
Home
Blog
About
Back
Income Statement
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)
source: myfinsight.com
Product
$79,412K
(19.28%↑ Y/Y)
License Collaboration
And Royalty Revenue
$3,808K
(10.89%↑ Y/Y)
Total revenue
$83,220K
(18.87%↑ Y/Y)
Income from operations
$46,341K
(130.75%↑ Y/Y)
Interest income
$3,393K
(6.36%↑ Y/Y)
Total operating
expenses
$36,879K
(-26.13%↓ Y/Y)
Other (income)
expense, net
$6,234K
(167.42%↑ Y/Y)
Net income before
income taxes
$48,786K
(120.19%↑ Y/Y)
Interest expense
$948K
(-15.13%↓ Y/Y)
Selling, general and
administrative
$23,508K
(-9.65%↓ Y/Y)
Research and development
$13,050K
(75.59%↑ Y/Y)
Cost of revenue
$6,555K
(-7.87%↓ Y/Y)
Net income
$37,414K
(73.91%↑ Y/Y)
Income tax expense
$11,372K
(1668.58%↑ Y/Y)
Comprehensive income
$37,317K
(74.11%↑ Y/Y)
Unrealized loss on
available-for-sale securities
-$97K
(-21.25%↓ Y/Y)
Back